Rausing laboratory of Lund - Tumor section
31 – 45 of 80
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Risk factors for need of reoperation in bilateral chronic subdural haematomas
(
- Contribution to journal › Article
-
Mark
Variations in the management of diffuse low-grade gliomas - A Scandinavian multicenter study
(
- Contribution to journal › Article
- 2020
-
Mark
Extreme intracranial pressure elevation > 90 mmHg in an awake patient with primary CNS lymphoma—case report
(
- Contribution to journal › Article
-
Mark
Growth pattern of experimental glioblastoma
(
- Contribution to journal › Article
-
Mark
S-100 protein levels in the blood of Fischer rats exposed to 915 MHz CW-microwaves and magnetic fields.
(
- Contribution to journal › Article
-
Mark
Radiotherapy and IDO-inhibition for Glioblastoma
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma
(
- Contribution to journal › Article
-
Mark
Novel treatments of glioblastoma in experimental models
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Electro-Pulse-Enhanced Cancer Therapy
2020) 1.(
- Book/Report › Book
- 2019
-
Mark
PO-0978 Accurate positioning with decreased treatment time using surface guided tomotherapy : ESTRO 38, 26-30 April 2019, Milan, Italy
(
- Contribution to journal › Published meeting abstract
-
Mark
Upregulation of C1-inhibitor in pancreatic cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Anti-C1-inactivator treatment of glioblastoma
(
- Contribution to journal › Article
-
Mark
Does time from diagnostic CT until surgical evacuation affect outcome in patients with chronic subdural hematoma?
(
- Contribution to journal › Article
-
Mark
IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis
(
- Contribution to journal › Article
-
Mark
Evaluating vacquinol-1 in rats carrying glioblastoma models RG2 and NS1
(
- Contribution to journal › Article